Aspen Aerogels (NYSE:ASPN) Given New $15.00 Price Target at Canaccord Genuity Group

Aspen Aerogels (NYSE:ASPN) had its price objective reduced by Canaccord Genuity Group from $20.00 to $15.00 in a research note published on Friday,Benzinga reports. They currently have a buy rating on the construction company’s stock.

ASPN has been the subject of a number of other reports. Roth Mkm reduced their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Craig Hallum reduced their price target on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Friday. Seaport Res Ptn downgraded shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a report on Saturday, February 8th. Finally, Barclays dropped their price objective on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Tuesday, November 12th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $24.67.

Aspen Aerogels Stock Down 3.7 %

ASPN opened at $8.67 on Friday. The company has a fifty day moving average price of $12.27 and a 200-day moving average price of $18.56. The firm has a market capitalization of $711.02 million, a P/E ratio of 867.47 and a beta of 2.14. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48. Aspen Aerogels has a one year low of $8.25 and a one year high of $33.15.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.06%. Equities research analysts expect that Aspen Aerogels will post 0.12 earnings per share for the current fiscal year.

Institutional Trading of Aspen Aerogels

Several hedge funds have recently added to or reduced their stakes in the business. Connors Investor Services Inc. bought a new stake in Aspen Aerogels in the fourth quarter worth $168,000. Schonfeld Strategic Advisors LLC bought a new stake in Aspen Aerogels in the fourth quarter worth $1,648,000. Northern Trust Corp lifted its stake in Aspen Aerogels by 13.7% in the fourth quarter. Northern Trust Corp now owns 641,050 shares of the construction company’s stock worth $7,616,000 after purchasing an additional 77,364 shares during the last quarter. Aquatic Capital Management LLC lifted its stake in Aspen Aerogels by 67.0% in the fourth quarter. Aquatic Capital Management LLC now owns 117,212 shares of the construction company’s stock worth $1,392,000 after purchasing an additional 47,012 shares during the last quarter. Finally, Nebula Research & Development LLC lifted its stake in Aspen Aerogels by 184.7% in the fourth quarter. Nebula Research & Development LLC now owns 46,787 shares of the construction company’s stock worth $556,000 after purchasing an additional 30,352 shares during the last quarter. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.